GRRC researcher identifies new therapeutic for Parkinson's treatment

September 25, 2024

 

For decades, Kathy Steece-Collier, PhD, professor of translational neuroscience, has been researching ways to improve the quality of life for Parkinson’s patients. Her work has led to a new gene therapy that could reduce or eliminate symptoms. Evidence also suggests this therapy has potential to halt progression of the disease.

Read about how her team is reshaping Parkinson's disease treatment.